Stay updated on LBR-101 Efficacy in Chronic Migraine Clinical Trial
Sign up to get notified when there's something new on the LBR-101 Efficacy in Chronic Migraine Clinical Trial page.

Latest updates to the LBR-101 Efficacy in Chronic Migraine Clinical Trial page
- Check3 days agoChange DetectedA centralized Locations section has been added listing study sites across AZ, CA, CO, CT, FL, GA, IN, KS, MA, MI, MN, MO, NV, NY, NC, OH, OK, PA, SC, TN, TX, and VA, with a revision from v3.3.2 to v3.3.3 replacing the prior state-specific location subsections.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedMinor textual updates in the Publications section clarify that publications are automatically filled from PubMed and update the Revision label from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding lapse notice that warned information on the page may not be up to date and that NIH operations could be disrupted.SummaryDifference0.3%

- Check54 days agoChange DetectedCore study details such as primary/secondary outcomes, eligibility criteria, enrollment, and locations appear unchanged; observed differences seem limited to layout or display elements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedUpdated the page to v3.2.0 with a prominent notice about potential data and transaction delays due to funding lapses; previous v3.1.0 version tag removed.SummaryDifference3%

- Check89 days agoChange DetectedAdded version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these deletions are intended, this is a major reduction in detailed drug-safety content.SummaryDifference0.4%

Stay in the know with updates to LBR-101 Efficacy in Chronic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LBR-101 Efficacy in Chronic Migraine Clinical Trial page.